Sinclair, Inc. (NASDAQ: SBGI ) recently reported a new agreement with YouTube, and noted beneficial expectations for favorable reforms in the near term. In my view, the most recent acquisitions reported in the last quarter and new acquisitions that could be announced in theBased in Europe, I am an independent investor with more than a decade of experience. I research cash flow statements and unlevered free cash flow figures. My articles may include a number of assumptions about the future free cash flow of ...

CINCINNATI, Ohio, June 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men’s health and oncology, today reported that on June 11, 2025, the Company received a decision from the Nasdaq Hearings Panel granting the Company’s request for continued listing on The Nasdaq Stock Market, subject to the Company demonstrating compliance with the Na ...

Group 1: Trade Tariffs and Onshoring - The recent trade tariffs implemented by President Trump are encouraging companies to onshore manufacturing in the United States, as globalization faces rising trade costs [1] - Major players in the semiconductor industry are making multi-billion-dollar investments to establish production plants in the U.S., which helps mitigate tariff costs and positions them favorably with the government [2][3] Group 2: Micron Technology's Investment Strategy - Micron Technology has decided to invest up to $200 billion in onshoring production capacity in the U.S., aiming to capitalize on the sector's shift towards domestic manufacturing [3] - Micron's stock currently trades at 74% of its 52-week high, indicating a significant gap compared to peers like NVIDIA and Taiwan Semiconductor, which are nearing their highs [4][5] Group 3: Market Sentiment and Analyst Ratings - Over the past month, Micron's stock saw a 6.4% reduction in short interest, indicating bearish capitulation ahead of the announcement regarding onshoring investments [6][7] - The 12-month stock price forecast for Micron is $129.00, suggesting an 11.59% upside potential based on 25 analyst ratings [8] - Institutional investors have shown strong interest, with $2.6 billion in institutional buying in the most recent quarter, adding to the previous quarter's $7.8 billion [9] Group 4: Earnings Forecast and Future Potential - Analysts forecast Micron's earnings per share (EPS) to reach $2.04 for Q4 2025, representing a potential increase of 30.8% from the current EPS of $1.56 [10][11]

Core Viewpoint - A lawsuit has been filed against Organon & Co. and certain senior executives for potential violations of federal securities laws, particularly related to misleading statements about the company's dividend policy following a significant acquisition [1][2][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of New Jersey, captioned Hauser v. Organon & Co., et al., No. 25-cv-05322, and claims are made under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [2]. - Investors have until July 22, 2025, to request to be appointed to lead the case [2]. Group 2: Company Background and Acquisition - Organon is a global healthcare company focused on women's health and has historically provided a healthy dividend to its shareholders [3]. - In October 2024, Organon completed a $1.2 billion acquisition of Dermavant, a biopharmaceutical company, which increased the company's debt [3]. Group 3: Dividend Policy and Stock Performance - Following the acquisition, Organon assured investors it would maintain its dividend, claiming it was the "1 capital allocation priority," but later shifted focus to debt reduction, leading to a severe cut in its dividend [3]. - On May 1, 2025, Organon announced a reduction in its dividend payout from $0.28 per share to $0.02 per share, resulting in a stock price decline of approximately 27%, from $12.93 on April 30, 2025, to $9.45 on May 1, 2025 [4].

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Reddit, Inc. (NYSE: RDDT) for potential violations of the federal securities laws. If you invested in Reddit, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/reddit-inc-securities-fraud-class-action. Why is Reddit being Investigated? Reddit owns and operates the eponymous social news aggregation, forum, and social med ...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Compass Diversified Holdings and Compass Group Diversified Holdings, LLC (NYSE: CODI) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Compass you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/compass-diversified-holdings. Investors ...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/iovance-biotherapeutics-inc-class-action-lawsuit. Investors have until July 14, 2 ...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ: FTRE) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/fortrea-holdings-inc-class-action-lawsuit. Investors have until August 1, 2025, to ask th ...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ: URGN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in UroGen you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/urogen-pharma-ltd-class-action-lawsuit. Investors have until July 28, 2025, to ask the Court ...

Darling Ingredients (DAR) shares rallied 9.2% in the last trading session to close at $36.01. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 6.6% loss over the past four weeks.Darling Ingredients stock is rising amid optimism surrounding recent developments, which suggest proposed rise in biofuel blending mandates. This policy shift may support stronger margins and improved performance across DAR’s core rene ...